John F Mantovani MD
Neurodevelopmental Disabilities
Medical Director Mercy Kids Therapy, Development and Autism Centers
Join to View Full Profile
12680 Olive BlvdSte 200St. Louis, MO 63141
Phone+1 314-529-5660
Fax+1 314-529-5665
Dr. Mantovani is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Washington University/B-JH/SLCH ConsortiumFellowship, Child Neurology, 1978 - 1979- Washington University/B-JH/SLCH ConsortiumResidency, Pediatrics, 1976 - 1978
- Washington University/B-JH/SLCH ConsortiumResidency, Pediatrics, 1975 - 1976
- Washington University/B-JH/SLCH ConsortiumInternship, Transitional Year, 1974 - 1975
University of Missouri-Columbia School of MedicineClass of 1974
Certifications & Licensure
MO State Medical License 1975 - 2027
AR State Medical License 2013 - 2018
WI State Medical License 1979 - 1997
American Board of Pediatrics Pediatrics
American Board of Psychiatry and Neurology Neurology with Special Qualification in Child Neurology- American Board of Psychiatry and Neurology Neurodevelopmental Disabilities
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2015-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2015-2017
Publications & Presentations
PubMed
- De novo variants in KDM2A cause a syndromic neurodevelopmental disorder.Eric N Anderson, Stephan Drukewitz, Sukhleen Kour, Anuradha V Chimata, Deepa S Rajan
American Journal of Human Genetics. 2026-01-08 - 2 citationsDe novo variants incause a syndromic neurodevelopmental disorder.Eric N Anderson, Stephan Drukewitz, Sukhleen Kour, Anuradha V Chimata, Deepa S Rajan
Medrxiv. 2025-04-01 - 46 citationsDe Novo and Bi-allelic Pathogenic Variants in NARS1 Cause Neurodevelopmental Delay Due to Toxic Gain-of-Function and Partial Loss-of-Function Effects.Andreea Manole, Stephanie Efthymiou, Emer O'Connor, Marisa I. Mendes, Matthew J. Jennings
American Journal of Human Genetics. 2020-08-06
Journal Articles
- Acquired aphasia with convulsive disorder: Course and prognosis.Mantovani, JF, Landau WM, Neurology, 1980
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
